by @topics.medsky.network
A Medsky Topics feed composed of posts covering recent news related to HIV & AIDS Powered by @medsky.network
The Lancet Reg Health-Americas The October 2026 issue of The Lancet Regional Health - Americas is now available online! lnkd.in/gSeFQ_dK In this issue, we covered #TraumaticBrainInjury, #HIV, #ChildhoodCancer, #CervicalCancer, #Malaria, #Tuberculosis, #OpioidAddiction, #Diabetes, and more.
Open Forum Infectious Diseases Durability of semaglutide effects after treatment discontinuation in HIV-associated lipohypertrophy: a randomized, double-blind, placebo-controlled phase IIb clinical trial ✅ Just Accepted 🔗 https://bit.ly/3TVRZkL
Open Forum Infectious Diseases Sexually Transmitted Infections Among Men Who Have Sex with Men Using Daily and Event-Driven HIV Pre-Exposure Prophylaxis: A Retrospective Cohort Study ✅ Just Accepted 🔗 https://bit.ly/4zqAIPH
HIVMA Join “Your Voice, Your Patients, Your Community: ID and HIV Advocacy in an Election Year” at #IDWeek2026 to hear from HIVMA advocates about engaging Congress on key ID and HIV priorities and learn how the 2026 midterm elections could shape the future. RSVP here: https://bit.ly/4rVsL2t
Rockefeller University Press In @jem.org, Merad, Yu, and Lichterfeld review how viral and host mechanisms let #HIV-1 reservoir cells persist for decades under ART, challenging classical latency models and arguing their immunological vulnerabilities can be exploited for cure strategies. rupress.org/jem/article/...
Journal of Experimental Medicine Merad, Yu, and Lichterfeld @ragoninstitute.bsky.social review how viral and host mechanisms let #HIV-1 reservoir cells persist for decades under ART, challenging classical latency models and arguing their immunological vulnerabilities can be exploited for cure strategies. rupress.org/jem/article/...
IAS - the International AIDS Society 🆕 New Journal of the International AIDS Society supplement! How can implementation research help turn #HIV evidence into action? Explore lessons learned, best practices & future directions for advancing the field. 📖 Read the supplement: https://onlinelibrary.wiley.com/toc/17582652/2026/29/S5
JAMA Network Open 📊 Long-acting lenacapavir and cabotegravir was associated with sustained #ViralSuppression among treatment-experienced people with HIV, including patients with adherence challenges and resistance. ja.ma/4B0VU0s
The Sick Times This week's #LongCOVID research updates from @mileswgriffis.bsky.social: thesicktimes.org/2026/10/06/r...
IAS - the International AIDS Society Last week, 118 participants came together in #Cairo at our #IASEdFund workshop. Discussions focused on expanding PrEP access, reducing #HIV-related stigma, community engagement & supporting implementation of #Egypt’s national AIDS strategy. 📷 View more highlights: www.instagram.com/p/DeOko5UDd4...
The Journal of Infectious Diseases The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infection 🔁 Repost 🔗 https://t.co/H4lU2m7TUS
HIVMA What do you do when HIV cases don’t have easy answers? Join the #IDWeek2026 session, “Challenging HIV Treatment and Prevention Clinical Cases” to work through cases involving antiretroviral resistance, drug interactions, treatment failure and more. Register: https://www.idweek.org/registration/
NEJM.org Among patients with HIV-1 suppression while receiving bictegravir–emtricitabine–tenofovir alafenamide (B/F/TAF), switching to weekly islatravir–lenacapavir was noninferior to continuing daily B/F/TAF in maintaining suppression. Full phase 3 ISLEND-1 trial results: https://nej.md/4b4s7sh
National Clinician Consultation Center (NCCC) We were thrilled to attend the National Ryan White Conference on HIV Care & Treatment in Washington, DC this summer! Read more about #NRWC2026 in our latest NCCC #EndHIVEpidemic Newsletter, which also covers the latest updates to national HIV practice guidelines and more. 📖 conta.cc/4rTH4on
The Center for Drug Use and HIV Research (CDUHR) Check out the latest from CDUHR affiliated investigator Ofole Mgbako- Honoring the Legacy of the HIV Epidemic "The courage shown by doctors and patients in the 1980s can help guide clinicians today." www.nejm.org/doi/full/10....
QBurgh Join Shepherd Wellness Community Oct. 8 for the Red Ribbon Benefit: A Community Cabaret! Music, dance, fashion, food & community—all supporting Shepherd Wellness Community’s programs for people living with HIV/AIDS. Tickets & info: www.zeffy.com/en-US/ticket...
Clinical Infectious Diseases Interpreting Post Hoc Noninferiority Analyses in Reduced-Frequency HIV Follow Up ✅ Just Accepted 🔗 https://bit.ly/4rQIMH0